eTheRNA raised €39m in Series B2 funding from Kenneth Chien, Marijn Dekkers and insiders LSP, PMV, Grand Pharma, Fund+ and Omega Fund

Biotech Health services

Investments

19 August 2022

eTheRNA (company)

Biotech Health services

Total investments received (USD): 77.84m

Round value (USD): 39.59m

Round investors: Fundplus LSP (Life Sciences Partners) Omega Funds PMV China Grand Pharmaceutical and Healthcare Holdings Kenneth Chien Marijn Dekkers

Company: eTheRNA

Industry: Biotech Health services

Biotech Health services Pharma

Investments 22 August 2022

Biotech Health services

Investments 08 July 2022